This assumes that those who have recovered from COVID-19 have developed special anti-virus proteins or antibodies in their plasma, which could therefore help sick patients cope with the disease.
The institute's director told Prime Minister Benjamin Netanyahu that the vaccine was being readied for testing in animals.
The announcement was part of a $1 billion deal made with the US government to create the manufacturing capacity for 1 billion vaccine doses.
The project is one of the several emergency projects that are the focus of around the clock work by 20 different labs at Technion-Institute of Technology
Vaccine expected to take 12 to 18 months, other therapies likely available much sooner, scientists say
Though regulatory processes and bureaucratic barriers are likely to be expedited, including the acceleration of clinical trials in humans, the world will need to be patient.
Kamada has announced that they have started to work on developing a blood-plasma derived treatment against the virus.
The ayatollah's office denied the report, stressing that "The Q&A on the subject never took place, and it is absolutely fake news."
Usually, the Health Ministry approves treatments through a long process that can last up to a year or longer.
The World Health Organization considers vaccine hesitancy – the reluctance or outright refusal to use vaccines despite how readily available they are – as one of the top 10 global health threats.